Sponsored Research Initiative Submission Form

Please disclose names, email addresses and a brief biography (max 1000 characters each) for up to four (4) authors below. If you have more than 4 authors, please email it to research@cbvinstitute.com

Author name:*

First Last

Email*

Author biography*

Co-author name (if applicable):

First Last

Co-author email (if applicable):

Co-author biography (if applicable):

Co-author name (if applicable):

First Last

Co-author email (if applicable):

Co-author biography (if applicable):

Co-author name (if applicable):

First Last

Co-author email (if applicable):

Co-author biography (if applicable):

*New for 2024: AI tools cannot be listed as an author of a paper. Should your submission be selected for sponsorship, the use of generative AI tools in the sponsored research initiative must be clearly disclosed in the research paper. For further information, please see the Committee On Publication Ethics (COPE) position statement on the use of generative AI tools: https://publicationethics.org/cope-position-statements/ai-author

Proposal information

Title of proposed research initiative:*

Description of research topic:*

Please describe the proposed research initiative.

Description of benefit:*

Please describe how the research initiative will benefit business valuation practitioners and further the CBV Institute’s objective - To encourage and support research activities, culminating in useful and relevant research papers on emerging issues of interest to CBVs and business valuation professionals.

Research plan:*

Please outline the research plan including subtopics within the scope of the research.

Research resources:*

Please list the preliminary research sources and methodologies to be employed and any potential challenges to gather the required information.

Funding requests

CBV Institute provides $10,000 compensation for a completed paper. Compensation is paid in installments, upon completion of the following milestones:

Does your research initiative require additional funds (above $10,000)?*

Yes
No

Please provide a detailed request for consideration by the Research Task Force, noting what is being requested, how it relates to the research initiative, and what it costs:*

Required Disclosures

Do you have any real or perceived conflicts of interest to declare?*

This may include financial, employment or other connections of the authors that could pose a real or perceived conflict of interest should your research proposal be selected for sponsorship.

Yes
No

Please disclose any real or perceived conflicts of interest:*

Do you have other sources of funding (existing or potential) for this research initiative?*

Yes
No

Please disclose any existing or potential funding:*

Additional supporting information

If the authors wish to provide supplementary material, please email it to research@cbvinstitute.com.

Acknowledgments*

The proposal author(s) acknowledge that CBV Institute and the successful authors(s) will be required to enter into an agreement for rights and responsibilities in connection with the awarded proposal and completed research paper.
The author(s) acknowledge that CBV Institute shall be entitled, in its sole discretion, to publish and distribute the final version of the research paper(s) in any format. No additional compensation will be paid to the author(s) of the research paper.
The author(s) acknowledge that the research paper must be original work (clearly distinguishable from other papers) without any restrictions on publication by CBV Institute.
The author(s) acknowledge that the research paper must maintain an appropriate quality standard as assessed by CBV Institute.
The author(s) acknowledge that each stage of the research paper and summary must be completed within the stated deadlines.

Sponsored Research Initiative - ENG

Proposal information

Funding requests

Required Disclosures

Additional supporting information

Timelines

Your web browser is outdated. For the best possible site experience, we encourage you to switch your browser to Microsoft Edge, Google Chrome or Firefox.